VR Adviser, LLC Q3 2025 Filing
Filed November 14, 2025
Portfolio Value
$1.8T
Holdings
33
Report Date
Q3 2025
Filing Type
13F-HR
All Holdings (33 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | APGEAPOGEE THERAPEUTICS INC | 8,493,321 | $337.4B | 18.99% | |
| 2 | MTSRMETSERA INC | 3,750,662 | $196.3B | 11.05% | |
| 3 | OCULOCULAR THERAPEUTIX INC | 13,161,462 | $153.9B | 8.66% | |
| 4 | CDTXCIDARA THERAPEUTICS INC | 946,788 | $90.7B | 5.10% | |
| 5 | VRDNVIRIDIAN THERAPEUTICS INC | 3,882,709 | $83.8B | 4.72% | |
| 6 | KALVKALVISTA PHARMACEUTICALS INC | 6,728,985 | $82.0B | 4.61% | |
| 7 | ORKAORUKA THERAPEUTICS INC | 4,148,428 | $79.8B | 4.49% | |
| 8 | ORICORIC PHARMACEUTICALS INC | 6,596,885 | $79.2B | 4.46% | |
| 9 | ELVNENLIVEN THERAPEUTICS INC | 3,226,331 | $66.0B | 3.72% | |
| 10 | COGTCOGENT BIOSCIENCES INC | 4,000,000 | $57.4B | 3.23% | |
| 11 | CTMXCYTOMX THERAPEUTICS INC | 15,561,500 | $49.6B | 2.79% | |
| 12 | ABVXABIVAX SA | 576,729 | $49.0B | 2.76% | |
| 13 | YB4PSAVARA INC | 12,681,043 | $45.3B | 2.55% | |
| 14 | SYRESPYRE THERAPEUTICS INC | 2,685,448 | $45.0B | 2.53% | |
| 15 | ERASERASCA INC | 17,857,083 | $38.9B | 2.19% | |
| 16 | DNTHDIANTHUS THERAPEUTICS INC | 960,803 | $37.8B | 2.13% | |
| 17 | ENGNENGENE HOLDINGS INC | 5,046,414 | $34.5B | 1.94% | |
| 18 | MAZEMAZE THERAPEUTICS INC | 1,230,769 | $31.9B | 1.80% | |
| 19 | JBIOJADE BIOSCIENCES INC | 3,220,364 | $27.8B | 1.56% | |
| 20 | DYNDYNE THERAPEUTICS INC | 2,173,913 | $27.5B | 1.55% | |
| 21 | VORVOR BIOPHARMA INC | 499,966 | $24.4B | 1.37% | |
| 22 | UPBUPSTREAM BIO INC | 1,169,298 | $22.0B | 1.24% | |
| 23 | ZURAZURA BIO LTD | 4,631,216 | $20.1B | 1.13% | |
| 24 | CATBUSDASTRIA THERAPEUTICS INC | 2,457,348 | $17.9B | 1.01% | |
| 25 | PHVSPHARVARIS N V | 674,599 | $16.8B | 0.95% | |
| 26 | CBIOCRESCENT BIOPHARMA INC. | 1,387,864 | $16.5B | 0.93% | |
| 27 | SEPNSEPTERNA INC | 610,808 | $11.5B | 0.65% | |
| 28 | CGEMCULLINAN THERAPEUTICS INC | 1,379,965 | $8.2B | 0.46% | |
| 29 | SRZNSURROZEN INC | 632,931 | $8.2B | 0.46% | |
| 30 | —PERCEPTIVE CAP SOLUTIONS COR | 750,000 | $8.0B | 0.45% | |
| 31 | ARTVARTIVA BIOTHERAPEUTICS INC | 1,609,569 | $4.6B | 0.26% | |
| 32 | TENXTENAX THERAPEUTICS INC | 437,708 | $3.3B | 0.19% | |
| 33 | —CASI PHARMACEUTICALS INC | 987,259 | $1.6B | 0.09% |